tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Relmada Therapeutics Highlights Strategic Progress to Shareholders
PremiumCompany AnnouncementsRelmada Therapeutics Highlights Strategic Progress to Shareholders
1M ago
Relmada Therapeutics CEO remains ‘optimistic’ about company’s future
Premium
The Fly
Relmada Therapeutics CEO remains ‘optimistic’ about company’s future
1M ago
Relmada Therapeutics CMO Purchases 55,000 Shares
Premium
Company Announcements
Relmada Therapeutics CMO Purchases 55,000 Shares
1M ago
Relmada Therapeutics appoints Lotan to Chair of Clinical Advisory Board
PremiumThe FlyRelmada Therapeutics appoints Lotan to Chair of Clinical Advisory Board
3M ago
Relmada Therapeutics Ends Esmethadone License Agreement
Premium
Company Announcements
Relmada Therapeutics Ends Esmethadone License Agreement
3M ago
Relmada Therapeutics Appoints New Chief Medical Officer
Premium
Company Announcements
Relmada Therapeutics Appoints New Chief Medical Officer
4M ago
Relmada Therapeutics’ Earnings Call: Promising Data Amid Financial Concerns
PremiumCompany AnnouncementsRelmada Therapeutics’ Earnings Call: Promising Data Amid Financial Concerns
5M ago
VA secretary wants to find answers on psychedelics therapies, Politico says
Premium
The Fly
VA secretary wants to find answers on psychedelics therapies, Politico says
5M ago
Psychedelic: Atai, Enveric, Incannex and Relmada report quarterly results
Premium
The Fly
Psychedelic: Atai, Enveric, Incannex and Relmada report quarterly results
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100